LEANN SCHWEDLER: Open Payments
NPI 1326430075 · MIDLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 15 payments from 4 companies in 2025. Trend: 2023 $510 · 2024 $340 · 2025 $305
Food & beverage: $291Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $149 |
| Gilead Sciences, Inc. | 4 | $103 |
| PFIZER INC. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: RINVOQ, XELJANZ, MAVYRET, SKYRIZI, EOHILIA.
Industry payments across MI — which companies pay providers there.
